STN: BL 125402/0
Proper Name: Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase
Tradename: HYQVIA
Manufacturer: Takeda Pharmaceuticals U.S.A., Inc.
Indication:
HYQVIA is an Immune Globulin Infusion 10% (Human) with a Recombinant Human Hyaluronidase (rHuPH20) indicated for the treatment of
- Primary Immunodeficiency (PI) in adults and pediatric patients two years of age and older.
- Maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
Product Information
Supporting Documents
-
Content current as of:
01/16/2024
